https://upjourney.com/exciting-healthcare-startups-to-watch-…6Ah4-sGT_c
Category: biotech/medical – Page 2,390
Julie K. Andersen at the Buck Institute for Research on Aging in Novato as a speaker for the 2019 Undoing Aging Conference.
“Julie has been associated with SENS since its earliest days: she participated in the first workshop that I organised to discuss it, in 2000, and she was a co-author on the first SENS paper in 2002. We’re delighted to be funding her laboratory at the Buck Institute to explore new ways of eliminating neurofibrillary tangles from neurons of Alzheimer’s sufferers, and at UA2019 we will hear about their initial progress.” says Aubrey de Grey.
https://www.undoing-aging.org/news/dr-julie-k-andersen-to-sp…Qq6fZbArkM #
#undoingaging #sens #foreverhealthy
Desiccants kill more than plants. Herbicides like glyphosate also kill bacteria. You could just as easily call them “antibiotics.” Our gut bacteria are sensitive to antibiotics, which is why we should avoid eating herbicides. When our microbes are healthy, our immune system is stable. But when microbes are disturbed, diseases like obesity, Alzheimer’s, or celiac disease can result.
Driving down a grid road in central Saskatchewan, a machine that looks like a giant insect approaches me in a cloud of dust. The cab, hanging 8 feet above the road, is suspended by tires at least 6 feet tall, with wing-like appendages folded along each side. Should I drive around it or under it?
It is harvest season, and the high-clearance sprayer is on its way to desiccate a field. Desiccation may be the most widespread farming practice you’ve never heard of. Farmers desiccate by applying herbicide to their crops; this kills all the plants at the same time, making them uniformly dry and easier to cut. In essence, desiccation speeds up plant aging. Before desiccation, crops would have to dry out naturally at the end of the season. Today, almost all conventional crops are desiccated in Canada, the United States, and the United Kingdom. Chances are that most of what you ate today was harvested using a desiccant, but you’d never know.
Mike Shewchuk jumps down from his swather as I pull into his farmyard. He is a young farmer whose blond brush cut and a robust stride would have not been out of place 50 years ago. Along with his dad, uncles, and brother, he farms 15,000 acres an hour outside of Saskatoon, Saskatchewan. They recently received a century farm award, for having continuously farmed the land since the early 1900s.
For the first time, a human organ has been successfully transported between medical facilities by a drone. A team of scientists from the University of Maryland Baltimore used a research-qualified donor kidney as a test subject to shuffle back and forth on a remotely piloted hexacopter, testing the organ for changes throughout 14 flights. Its longest journey was 3 miles at a maximum speed of 40 mph, the duration and distance of which were suitable for demonstrating transportation between inner city hospitals.
Currently, organs have few options for transportation, and the process for moving them involves a network of couriers and commercial aircraft that are dependent on schedules and traffic patterns. When normal commercial schedules aren’t available, the cost of private charter transportation can be prohibitive. Even when cost isn’t a factor, the time involved in the process altogether can prevent a transplant from being completed as organs are very sensitive cargo.
To best ensure a successful transplant procedure, organs must be moved quickly between the donor and the recipient. The amount of time an organ can spend chilled after removal and when it’s warmed up and the blood supply restored, called cold ischemia time (CIT), is very limited. Some organs, such as the heart, only have as few as 4 hours available to be transported before they are no longer eligible for transplant. Up against airplane flight availability and traffic patterns, an improvement like what drone transportation could provide might have life saving implications.
We wanted to bring your attention to a recent publication that discusses the topic of cellular senescence and the contributions of senescent cells to aging and disease [1].
What is perhaps the most interesting part of this paper is the section covering the potential future directions that researchers may take in managing senescent cell populations in order to mitigate age-related disease.
The author writes not only about the direct destruction of senescent cells via senolytic drugs but also about the modulation of the harmful secretions these cells produce, which are called the senescence-associated secretory phenotype (SASP).
People with the rare and fatal brain disorder Creutzfeldt-Jakob disease (CJD) show signs of the disease in their eyes, according to a new study.
The study found evidence of prions — the infectious proteins that cause the disease — in the eyes of nearly a dozen patients with CJD.
The findings suggest that patients’ eyes could potentially provide a “window” to the brain that may help researchers diagnose the disease early, if new eye tests are developed. [’Eye’ Can’t Look: 9 Eyeball Injuries That Will Make You Squirm].
On January 29–31, 2019, the Longevity Therapeutics Summit is happening at the Argonaut Hotel in San Francisco, California. The conference is a great networking opportunity with some leading names in aging research giving talks during the event.
This will be a two-day conference plus a pre-conference workshop hosted by our good friend Kelsey Moody from Ichor Therapeutics. During the workshop, Kelsey will be giving his personal insights into launching and developing a successful biotech company, particularly the challenges faced in the field of rejuvenation biotechnology. This is sure to be a highly informative workshop and well worth your time, especially if you are interested in launching your own company in this field, but even if you are not, it may still prove interesting to learn about this challenging industry.
This conference aims at bringing together leading figures in biology, biotechnology, omics, investment, and other fields in order to discuss how to further accelerate progress in aging research so that the time between basic research and clinical use is as short as possible.
Bionic Vision Technologies, a firm based in Australia, has announced that its bionic eye system has been used to restore a “sense of sight” to four completely blind people suffering from retinitis pigmentosa. The findings from the study, which was performed at Royal Victorian Eye and Ear Hospital in Melbourne, were presented at the Royal Australian and New Zealand College of Ophthalmologists Scientific meeting.
Unlike previous studies of the technology that were limited to in-lab use, the four patients were able to use the system in their everyday environments.